AI Analysis
AI-generated analysis. Always verify with the original filing.
Innate Pharma S.A. announced that its executive team will participate in one-on-one investor meetings at the Kempen Life Sciences Conference in Amsterdam on April 15–16, 2026.
Key Takeaways
1Executive team will attend Kempen Life Sciences Conference for investor meetings.
2Conference dates are April 15–16, 2026, located in Amsterdam, Netherlands.
3Format is one-on-one investor meetings; no presentation is explicitly disclosed.
4Company continues advancing portfolio including IPH4502, lacutamab, and monalizumab.